PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
1-Year Est. Return
73.17%
1 Year Est. Return
+73.17%
AUM
$2.67B
AUM Growth
-$155M
(-5.5%)
Holding
105
Top Buys
| 1 | +$166M | |
| 2 | +$44.4M | |
| 3 | +$37.5M | |
| 4 |
CAI
Caris Life Sciences
CAI
|
+$29.3M |
| 5 |
Neurocrine Biosciences
NBIX
|
+$19.5M |
Top Sells
| 1 | +$104M | |
| 2 | +$99.9M | |
| 3 | +$90.2M | |
| 4 |
Amicus Therapeutics
FOLD
|
+$80.5M |
| 5 |
Iovance Biotherapeutics
IOVA
|
+$42.3M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CAI
26
Caris Life Sciences
CAI
$8.86B
| $29.3M | 1.09% |
+1,098,163
|
|
||
27
Intuitive Surgical
ISRG
$160B
| $24.5M | 0.91% |
45,119
+4,500
|
|
||
28
ADMA Biologics
ADMA
$3.43B
| $23.7M | 0.88% |
1,303,468
-69,765
|
|
||
|
BBNX
29
Beta Bionics
BBNX
$870M
| $23.2M | 0.86% |
1,593,608
|
|
||
30
Spyre Therapeutics
SYRE
$1.74B
| $22.9M | 0.85% |
1,529,445
-783,827
|
|
||
31
Evolus
EOLS
$414M
| $22.8M | 0.85% |
2,474,843
-1,654,299
|
|
||
32
Celcuity
CELC
$2.2B
| $21.8M | 0.81% |
1,633,208
-729,071
|
|
||
33
Dyne Therapeutics
DYN
$2.33B
| $21.4M | 0.79% |
2,247,390
-66,013
|
|
||
|
SION
34
Sionna Therapeutics
SION
$1.41B
| $21.1M | 0.78% |
1,216,045
-35,056
|
|
||
35
Axsome Therapeutics
AXSM
$6.38B
| $20.7M | 0.77% |
198,534
-156,573
|
|
||
36
Repligen
RGEN
$8.58B
| $20.6M | 0.77% |
166,000
+36,199
|
|
||
37
Insulet
PODD
$22.4B
| $19M | 0.7% |
60,387
-11,210
|
|
||
38
Outset Medical
OM
$235M
| $16M | 0.59% |
833,333
|
|
||
39
Zymeworks
ZYME
$1.39B
| $16M | 0.59% |
1,275,274
-589,398
|
|
||
40
CytomX Therapeutics
CTMX
$528M
| $15.9M | 0.59% |
+6,993,646
|
|
||
41
Aldeyra Therapeutics
ALDX
$316M
| $15.5M | 0.58% |
4,051,631
-5,224,220
|
|
||
42
Charles River Laboratories
CRL
$8.79B
| $15.2M | 0.56% |
+100,000
|
|
||
|
CNTA
43
Centessa Pharmaceuticals
CNTA
$3.09B
| $15.1M | 0.56% |
1,146,935
-1,893,460
|
|
||
44
Inhibrx
INBX
$540M
| $14M | 0.52% |
977,892
-86,134
|
|
||
|
ADGM
45
Adagio Medical Holdings
ADGM
$21.2M
| $12.8M | 0.48% |
9,876,576
+64,157
|
|
||
46
Nurix Therapeutics
NRIX
$757M
| $12.5M | 0.46% |
1,096,985
+799,432
|
|
||
47
Travere Therapeutics
TVTX
$2.44B
| $12.3M | 0.46% |
+834,252
|
|
||
48
Orchestra BioMed
OBIO
$179M
| $12.3M | 0.46% |
4,592,556
|
|
||
|
DRUG
49
Bright Minds Biosciences
DRUG
$448M
| $11M | 0.41% |
420,690
-23,959
|
|
||
50
Inhibikase Therapeutics
IKT
$117M
| $10.6M | 0.39% |
5,432,293
-492,707
|
|